Charles Morgan Kendrick JR - Mar 3, 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & President, Commercial
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 3, 2025
Transactions value $
-$2,267,041
Form type
4
Date filed
3/5/2025, 05:52 PM
Previous filing
Nov 5, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$878K -2.22K -23.86% $395.50 7.09K Mar 3, 2025 Direct F1
transaction ELV Common Stock Award $0 +2.85K +40.13% $0.00 9.93K Mar 3, 2025 Direct F2
transaction ELV Common Stock Award $0 +3.69K +37.1% $0.00 13.6K Mar 3, 2025 Direct F3
transaction ELV Common Stock Sale -$1.39M -3.5K -25.73% $396.30 10.1K Mar 5, 2025 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +10.8K $0.00 10.8K Mar 3, 2025 Common Stock 10.8K $395.50 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 948 shares each on 3/3/2026 and 3/3/2027, and 949 shares on 3/3/2028.
F3 Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
F4 This transaction was executed in multiple trades, each at the same price of $396.30.
F5 Balance includes 22.89 shares acquired on December 20, 2024 through a dividend reinvestment plan.
F6 The option represents a right to purchase a total of 10,828 shares, and is exercisable in three annual installments, with two installments of 3,609 shares each and one installment of 3,610 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.